1.0Public Citizenhttps://www.citizen.orgDiane Krauthamerhttps://www.citizen.org/author/dkrauthamer/rich600338<blockquote class="wp-embedded-content" data-secret="rMTMigK9zf"><a href="https://www.citizen.org/article/testimony-on-public-health-dangers-of-prescription-to-otc-switch-of-lovastatin-mevacor/">Testimony on Public Health Dangers of Prescription-to-OTC Switch of Lovastatin (Mevacor)</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://www.citizen.org/article/testimony-on-public-health-dangers-of-prescription-to-otc-switch-of-lovastatin-mevacor/embed/#?secret=rMTMigK9zf" width="600" height="338" title="“Testimony on Public Health Dangers of Prescription-to-OTC Switch of Lovastatin (Mevacor)” — Public Citizen" data-secret="rMTMigK9zf" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript"> /* <![CDATA[ */ /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); /* ]]> */ </script> A substantial percentage of those who would choose to use the OTC version of this drug, if it were made available, have a risk for Coronary Heart Disease that is so low that there is no evidence they will benefit from the drug. Thus, they would be subjected to the various risks of adverse reactions without any possibility of benefit. Thus the risks clearly outweigh the benefits for this group.https://www.citizen.org/wp-content/uploads/public_citizen_shared_link.jpg1200628